Advertisement
NOVT vs ST
Which Stock Would AI Choose? Novanta Inc. (NOVT) vs. Sensata Technologies Holding (ST) Stock Comparison
Key Takeaways
- Novanta Inc. (NOVT) recently completed a transformative $1.5 billion acquisition of Riverpoint Medical, roughly doubling its recurring medical consumables revenue and pushing medical end-market exposure toward 60% of total revenue.
- Sensata Technologies Holding (ST) is executing a corporate transformation that has delivered sharply improved free cash flow, a strengthened balance sheet, and a return to organic revenue growth after a period of managed decline.
- NOVT has gained approximately 18% year-to-date, while ST has surged roughly 38% in the same period, reflecting a meaningful divergence in market momentum.
- The two companies operate in different segments of the industrial technology landscape: NOVT is increasingly weighted toward medical and surgical technologies, while ST remains anchored in automotive and industrial sensor applications.
- ST pays a quarterly dividend ($0.12 per share) and has an active share repurchase program; NOVT does not currently pay a dividend, reinvesting capital into M&A (mergers and acquisitions) and organic growth.
Introduction
Investors evaluating opportunities in the industrial and precision technology sectors often encounter two distinctly positioned names: Novanta Inc. and Sensata Technologies Holding. Though both supply critical components to original equipment manufacturers (OEMs) worldwide, their business models, end-market exposures, and growth trajectories could hardly be more different. Novanta is a fast-consolidating player in precision medicine and advanced industrial automation, while Sensata is a global sensor and electrical protection powerhouse presently navigating a multi-year operational transformation. This stock comparison examines how NOVT and ST stack up across recent performance, catalysts, risk profiles, and relative market positioning, offering a balanced view for traders and investors assessing these two names side by side.
NOVT Overview and Recent Performance
Novanta Inc. is a Bedford, Massachusetts-based supplier of proprietary technology solutions to medical and advanced industrial OEMs. The company operates through two primary segments: Automation Enabling Technologies, which encompasses laser beam delivery, precision motion control, and robotic end-of-arm tooling; and Medical Solutions, which includes insufflators, endoscopic pumps, RFID (Radio Frequency Identification) technologies, and surgical visualization systems. Holding approximately 750 patents, Novanta has built its competitive moat around deeply engineered, sole-sourced components that are embedded in customers' products during long design cycles.
In recent market activity, NOVT shares have traded around the $140 level, with a 52-week range spanning from approximately $98 to $172. The company's market capitalization stands near $5 billion, and its year-to-date performance through late July 2026 has been positive at roughly 18%. The dominant catalyst shaping sentiment in recent weeks has been the completion of Novanta's $1.5 billion acquisition of Riverpoint Medical, a category leader in minimally invasive surgical consumables — including advanced surgical fibers, suture anchors, and implantable materials for sports medicine and cardiovascular applications. Management has stated that the deal is expected to double Novanta's recurring medical consumables revenue to approximately $300 million and push medical end-market exposure to 60% of total company revenue. The transaction, which was financed through a combination of cash, credit facilities, and a $300 million private placement, is projected to contribute $0.18 to $0.25 in adjusted EPS (earnings per share) in 2027. This acquisition represents a significant pivot toward higher-margin, recurring-revenue medical consumables and has been well-received by the analyst community, which maintains a consensus Strong Buy rating with a median price target of $175.
ST Overview and Recent Performance
Sensata Technologies Holding plc, headquartered in Swindon, United Kingdom, is a global industrial technology company and one of the world's leading suppliers of sensor-based solutions and electrical protection products. The firm designs and manufactures pressure, temperature, force, and position sensors, as well as contactors and relays, serving automotive, heavy vehicle, industrial, HVAC (heating, ventilation, and air conditioning), and aerospace markets. Following a recent reorganization, Sensata now reports results across three segments: Automotive; Industrials; and Aerospace, Defense and Commercial Equipment.
ST shares have staged an impressive rally in recent months, trading near the $46 mark as of late July 2026, with a 52-week range of approximately $28 to $54. The company's market capitalization has expanded to roughly $6.75 billion, and its year-to-date return of approximately 38% significantly outpaces the broader market. This momentum is rooted in a multi-year transformation initiative that has meaningfully improved financial resilience. Full-year 2025 revenue came in at $3.7 billion, down 5.8% year-over-year due to previously disclosed divestitures and product lifecycle management actions, but organic revenue — a metric that strips out acquisitions, divestitures, and currency effects — turned slightly positive for the full year. More notably, Sensata generated $490.2 million in free cash flow (FCF) during 2025, representing a 97% FCF conversion rate, a dramatic improvement from prior periods. The company also returned $191 million to shareholders through dividends and buybacks. Adjusted EPS for 2025 was $3.42, essentially flat year-over-year on an adjusted basis despite revenue headwinds, reflecting improved operational discipline.
Trending AI Robots
For traders looking to complement their own analysis with algorithm-driven insights, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate diverse market conditions. Tickeron hosts hundreds of AI trading bots spanning thousands of tickers, each with distinct trading styles, strategies, timeframes, performance metrics, and risk parameters. Only the strongest and most timely performers earn placement in the Trending AI Robots section — a dynamic showcase updated to reflect the bots best suited to prevailing market dynamics. Some featured bots have demonstrated win rates exceeding 70%, while others focus on momentum-based swing trades, mean-reversion strategies, or sector-specific rotations. Whether targeting short-term volatility or longer-term trend following, the platform's curated selection helps traders identify AI-driven strategies that align with current opportunities. Explore the Trending AI Robots page to see which bots are leading the pack right now.
Head-to-Head Comparison
When placed side by side, NOVT and ST reveal a study in contrasts across nearly every relevant investment dimension.
Business Model and End Markets: Novanta is increasingly a medical technology story, with surgical consumables and precision medicine applications now approaching 60% of revenue following the Riverpoint acquisition. Its remaining exposure spans advanced industrial automation, robotics, and laser technologies. Sensata, by contrast, derives the majority of its revenue from the automotive sector — particularly "bumper-in" sensor applications — with growing but smaller contributions from aerospace, defense, and industrial end markets. Novanta's revenue base is smaller (roughly $1 billion annually) but growing faster and tilted toward higher-margin medical applications, while Sensata's $3.7 billion revenue base provides scale but faces cyclical and structural pressures in legacy automotive markets.
Growth Drivers: Novanta's near-term growth narrative centers squarely on the Riverpoint Medical integration, which unlocks an estimated $2 billion incremental addressable market and is expected to be immediately accretive to organic growth, gross margins, and EBITDA (earnings before interest, taxes, depreciation, and amortization). Sensata's growth story is more internally driven — the company is improving margins through operational discipline, deleveraging its balance sheet, and gradually pivoting toward higher-growth aerospace and defense applications while managing headwinds from electric vehicle (EV) policy uncertainty.
Recent Momentum and Sentiment: On a price-performance basis, ST has been the clear winner in 2026, with a year-to-date gain near 38% versus roughly 18% for NOVT. Sensata's sharp free cash flow improvement and return to organic growth have resonated strongly with the market. Novanta's performance, while solid, has been tempered by the dilutive equity raise that partially funded the Riverpoint deal.
Risk Factors: Novanta faces integration risk with its largest-ever acquisition and carries elevated financial leverage following the transaction. The company's P/E (price-to-earnings) ratio exceeds 100 on a trailing basis, reflecting depressed GAAP earnings and high expectations. Sensata carries its own set of risks, including exposure to tariff policy volatility, a large goodwill impairment charge taken in 2025 related to its Dynapower clean-energy business, and persistent uncertainty around the pace of automotive electrification.
Shareholder Returns: Sensata offers a quarterly dividend of $0.12 per share and actively repurchases stock — tangible return-of-capital features that income-oriented investors may find appealing. Novanta does not pay a dividend, preferring to channel free cash flow toward strategic M&A and organic reinvestment.
Tickeron AI Verdict
Based on observable market data, trend consistency, and relative positioning, Tickeron's AI analysis would likely express a near-term preference for ST over NOVT in the current market environment. Sensata's stronger price momentum, dramatically improved free cash flow generation, and return to organic revenue growth provide a clearer, more measurable catalyst set that aligns well with trend-following and momentum-oriented signals. The company's successful operational transformation is showing tangible results in margins and cash conversion, factors that algorithmic models tend to weight favorably. Novanta's Riverpoint acquisition is undoubtedly a compelling long-term catalyst, but the elevated integration risk, post-deal leverage, and near-term equity dilution introduce variables that create a wider range of probable outcomes — making the stock's trajectory somewhat less predictable in the immediate term. That said, if the Riverpoint integration proceeds smoothly and delivers the projected accretion, NOVT could present a powerful re-rating opportunity; the AI framework would simply await confirming data from upcoming quarterly results before assigning higher conviction. As always, AI-driven assessments are probabilistic in nature and should be considered alongside broader portfolio context and individual risk tolerance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NOVT is a Hold and ST is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NOVT’s FA Score shows that 1 FA rating(s) are green whileST’s FA Score has 1 green FA rating(s).
- NOVT’s FA Score: 1 green, 4 red.
- ST’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NOVT’s TA Score shows that 2 TA indicator(s) are bullish while ST’s TA Score has 3 bullish TA indicator(s).
- NOVT’s TA Score: 2 bullish, 6 bearish.
- ST’s TA Score: 3 bullish, 6 bearish.
Price Growth
NOVT (@Electronic Equipment/Instruments) experienced а +0.71% price change this week, while ST (@Electronic Equipment/Instruments) price change was +1.27% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -1.38%. For the same industry, the average monthly price growth was -8.67%, and the average quarterly price growth was +3.13%.
Reported Earning Dates
NOVT is expected to report earnings on Aug 05, 2026.
ST is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Electronic Equipment/Instruments (-1.38% weekly)This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
| NOVT | ST | NOVT / ST | |
| Capitalization | 5.08B | 6.74B | 75% |
| EBITDA | 179M | 555M | 32% |
| Gain YTD | 19.800 | 39.889 | 50% |
| P/E Ratio | 102.55 | 74.66 | 137% |
| Revenue | 1.01B | 3.78B | 27% |
| Total Cash | 389M | 403M | 97% |
| Total Debt | 290M | 2.45B | 12% |
NOVT | ST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 94 | 100 | |
SMR RATING 1..100 | 85 | 88 | |
PRICE GROWTH RATING 1..100 | 55 | 41 | |
P/E GROWTH RATING 1..100 | 14 | 11 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ST's Valuation (59) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for NOVT (92). This means that ST’s stock grew somewhat faster than NOVT’s over the last 12 months.
NOVT's Profit vs Risk Rating (94) in the Electronic Equipment Or Instruments industry is in the same range as ST (100). This means that NOVT’s stock grew similarly to ST’s over the last 12 months.
NOVT's SMR Rating (85) in the Electronic Equipment Or Instruments industry is in the same range as ST (88). This means that NOVT’s stock grew similarly to ST’s over the last 12 months.
ST's Price Growth Rating (41) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (55). This means that ST’s stock grew similarly to NOVT’s over the last 12 months.
ST's P/E Growth Rating (11) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (14). This means that ST’s stock grew similarly to NOVT’s over the last 12 months.
| NOVT | ST | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 72% | 3 days ago 72% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 60% |
| MACD ODDS (%) | 3 days ago 75% | 3 days ago 62% |
| TrendWeek ODDS (%) | 3 days ago 66% | 3 days ago 62% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 64% |
| Advances ODDS (%) | 3 days ago 65% | 6 days ago 60% |
| Declines ODDS (%) | 7 days ago 68% | 11 days ago 69% |
| BollingerBands ODDS (%) | N/A | 3 days ago 81% |
| Aroon ODDS (%) | 3 days ago 66% | 3 days ago 69% |
Advertisement
NOVT and
Correlation & Price change
A.I.dvisor indicates that over the last year, NOVT has been loosely correlated with ST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NOVT jumps, then ST could also see price increases.
| Ticker / NAME | Correlation To NOVT | 1D Price Change % | ||
|---|---|---|---|---|
| NOVT | 100% | +2.62% | ||
| ST - NOVT | 52% Loosely correlated | -3.54% | ||
| VPG - NOVT | 51% Loosely correlated | +4.70% | ||
| BKSY - NOVT | 40% Loosely correlated | +2.63% | ||
| VNT - NOVT | 38% Loosely correlated | +0.75% | ||
| CGNX - NOVT | 36% Loosely correlated | +4.18% | ||
More | ||||
ST and
Correlation & Price change
A.I.dvisor indicates that over the last year, ST has been loosely correlated with KEYS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ST jumps, then KEYS could also see price increases.